Document is current
Any future updates will be listed below
-
Authors
Magosi, Lerato E. https://orcid.org/0000-0002-3388-9892
Tchetgen, Eric Tchetgen
Novitsky, Vlad
Pretorius Holme, Molly
Moore, Janet
Bachanas, Pam
Lebelonyane, Refeletswe
Fraser, Christophe
Moyo, Sikhulile https://orcid.org/0000-0003-3821-4592
Hurwitz, Kathleen E.
Gaolathe, Tendani
Goyal, Ravi
Makhema, Joseph
Lockman, Shahin
Essex, Max
De Gruttola, Victor https://orcid.org/0000-0003-2772-6242
Lipsitch, Marc https://orcid.org/0000-0003-1504-9213
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 19 February 2026
First Online: 14 March 2026
Competing interests
: Consulting fees. M.L.: Merck, University of Virginia Miller Center, Janssen. Unpaid consulting. M.L.: Janssen, Pfizer, Astra Zeneca; Payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing or educational events. M.L.: Sanofi Pasteur, Bristol Myers Squibb; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. S.L.: Member, Finance Board; member, Board of Directors; both for the Botswana Harvard AIDS Institute Partnership (unpaid). The remaining authors declare no competing interests.
